| Code | Description | Claims | Beneficiaries | Total Paid |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
78,705 |
72,026 |
$10.06M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
55,544 |
51,518 |
$6.93M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
56,110 |
51,700 |
$6.70M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
22,844 |
19,796 |
$5.99M |
| G0378 |
Hospital observation service, per hour |
21,803 |
18,501 |
$3.53M |
| H0015 |
Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education |
8,245 |
977 |
$1.91M |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
8,381 |
4,238 |
$1.84M |
| 59025 |
Fetal non-stress test |
6,924 |
4,696 |
$1.15M |
| 80053 |
Comprehensive metabolic panel |
47,752 |
35,877 |
$1.12M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
14,372 |
12,580 |
$853K |
| 64615 |
|
4,233 |
3,899 |
$797K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
82,311 |
74,107 |
$714K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
5,239 |
4,568 |
$685K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
391 |
365 |
$537K |
| 0002A |
|
6,420 |
6,076 |
$533K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
8,930 |
8,371 |
$520K |
| 20610 |
|
3,595 |
2,591 |
$484K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
137,141 |
118,337 |
$428K |
| J0178 |
Injection, aflibercept, 1 mg |
661 |
560 |
$401K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
2,011 |
1,358 |
$401K |
| 0001A |
|
4,734 |
4,477 |
$396K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
71,352 |
59,585 |
$386K |
| 92134 |
|
14,584 |
13,396 |
$384K |
| 31231 |
|
1,638 |
1,513 |
$344K |
| 36415 |
Collection of venous blood by venipuncture |
96,434 |
83,608 |
$344K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
25,679 |
21,878 |
$335K |
| 31579 |
|
728 |
666 |
$304K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
17,152 |
9,258 |
$298K |
| 80197 |
|
7,776 |
5,573 |
$297K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
7,326 |
6,675 |
$295K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
1,000 |
973 |
$281K |
| 87536 |
|
4,098 |
3,795 |
$258K |
| 92083 |
|
3,511 |
3,349 |
$247K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
10,736 |
9,391 |
$214K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
3,477 |
3,125 |
$208K |
| 64483 |
|
313 |
298 |
$189K |
| 81003 |
|
11,308 |
9,966 |
$187K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
9,214 |
4,836 |
$187K |
| 97803 |
|
2,660 |
2,380 |
$180K |
| 93798 |
|
2,270 |
400 |
$170K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
7,326 |
6,675 |
$167K |
| 90715 |
|
2,297 |
2,200 |
$162K |
| 36512 |
|
301 |
268 |
$162K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,142 |
1,088 |
$156K |
| 90686 |
|
4,182 |
3,935 |
$150K |
| C9257 |
Injection, bevacizumab, 0.25 mg |
270 |
232 |
$149K |
| 51798 |
|
2,673 |
2,515 |
$140K |
| 84484 |
|
5,783 |
3,372 |
$138K |
| 71046 |
Radiologic examination, chest; 2 views |
6,974 |
6,223 |
$137K |
| 0004A |
|
1,956 |
1,920 |
$129K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,312 |
1,140 |
$129K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
5,569 |
5,191 |
$120K |
| 86780 |
|
5,296 |
4,976 |
$117K |
| 81025 |
|
6,302 |
5,815 |
$101K |
| J3490 |
Unclassified drugs |
166,695 |
73,951 |
$99K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
7,663 |
7,260 |
$93K |
| 86850 |
|
3,567 |
3,265 |
$92K |
| 97535 |
Self-care/home management training, each 15 minutes |
2,020 |
1,572 |
$92K |
| 92133 |
|
3,646 |
3,504 |
$91K |
| 95806 |
|
272 |
263 |
$91K |
| 85027 |
|
15,174 |
13,742 |
$88K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,538 |
1,254 |
$87K |
| 46607 |
|
179 |
159 |
$82K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
60,229 |
54,114 |
$80K |
| 80076 |
|
6,638 |
6,159 |
$79K |
| 64405 |
|
501 |
454 |
$77K |
| J9035 |
Injection, bevacizumab, 10 mg |
136 |
116 |
$75K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
804 |
768 |
$72K |
| 86140 |
|
5,256 |
5,000 |
$71K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
313 |
277 |
$70K |
| 83735 |
|
8,318 |
4,240 |
$69K |
| 97602 |
|
330 |
274 |
$69K |
| 99215 |
Prolong outpt/office vis |
9,396 |
8,903 |
$69K |
| 86900 |
|
3,675 |
3,345 |
$68K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
3,150 |
2,935 |
$63K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
4,194 |
3,906 |
$61K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
800 |
752 |
$60K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
21,482 |
19,990 |
$59K |
| J0741 |
Injection, cabotegravir and rilpivirine, 2mg/3mg |
29 |
26 |
$58K |
| 84443 |
Thyroid stimulating hormone (TSH) |
5,192 |
4,919 |
$57K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
157 |
138 |
$56K |
| 20553 |
|
636 |
590 |
$56K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
252 |
225 |
$56K |
| 82105 |
|
965 |
905 |
$55K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
45,469 |
41,903 |
$53K |
| 85610 |
|
8,685 |
6,962 |
$52K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,124 |
554 |
$50K |
| 94726 |
|
240 |
229 |
$50K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
74 |
66 |
$47K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
928 |
877 |
$44K |
| 74183 |
|
196 |
188 |
$44K |
| 73610 |
|
825 |
709 |
$43K |
| 87150 |
|
1,469 |
1,400 |
$43K |
| 74160 |
|
13 |
12 |
$42K |
| 70450 |
Computed tomography, head or brain; without contrast material |
221 |
195 |
$42K |
| 83880 |
|
1,336 |
1,129 |
$41K |
| 86762 |
|
2,346 |
2,196 |
$38K |
| 87205 |
|
1,692 |
1,572 |
$38K |
| 80061 |
Lipid panel |
3,093 |
2,638 |
$38K |
| 11721 |
|
2,068 |
1,994 |
$37K |
| 86361 |
|
1,515 |
1,397 |
$36K |
| 93505 |
|
28 |
24 |
$36K |
| 17311 |
|
95 |
91 |
$35K |
| J9312 |
Injection, rituximab, 10 mg |
24 |
24 |
$34K |
| 87653 |
|
561 |
520 |
$34K |
| 72197 |
|
127 |
119 |
$34K |
| 73562 |
|
891 |
655 |
$33K |
| 0064A |
|
471 |
461 |
$33K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
9,922 |
5,206 |
$33K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
1,288 |
836 |
$32K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
439 |
284 |
$32K |
| 92235 |
|
203 |
194 |
$32K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,982 |
1,637 |
$31K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
35,176 |
30,783 |
$31K |
| 87340 |
|
3,112 |
2,903 |
$31K |
| 86803 |
|
1,938 |
1,817 |
$31K |
| 73630 |
|
732 |
563 |
$31K |
| 96900 |
|
996 |
249 |
$31K |
| 97124 |
|
1,182 |
594 |
$31K |
| 64400 |
|
175 |
103 |
$31K |
| 0003A |
|
354 |
347 |
$30K |
| 31575 |
|
160 |
147 |
$29K |
| 88142 |
|
2,057 |
1,952 |
$28K |
| 86769 |
|
707 |
679 |
$28K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
600 |
573 |
$28K |
| 52000 |
|
51 |
49 |
$28K |
| 87799 |
|
1,323 |
1,029 |
$27K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
58 |
52 |
$27K |
| 73030 |
|
469 |
401 |
$26K |
| 82565 |
|
38,300 |
33,980 |
$25K |
| 94729 |
|
328 |
315 |
$24K |
| 84100 |
|
15,451 |
9,576 |
$24K |
| 94010 |
|
481 |
426 |
$24K |
| P9047 |
Infusion, albumin (human), 25%, 50 ml |
65 |
26 |
$23K |
| 81001 |
|
19,520 |
18,002 |
$23K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,836 |
1,319 |
$22K |
| 86901 |
|
3,673 |
3,343 |
$22K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
230 |
222 |
$21K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,551 |
2,181 |
$21K |
| 92587 |
|
165 |
155 |
$21K |
| G0239 |
Therapeutic procedures to improve respiratory function or increase strength or endurance of respiratory muscles, two or more individuals (includes monitoring) |
1,108 |
258 |
$21K |
| J7321 |
Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose |
124 |
66 |
$20K |
| 80321 |
|
93 |
89 |
$20K |
| Q3014 |
Telehealth originating site facility fee |
17,637 |
13,080 |
$20K |
| 97165 |
|
447 |
407 |
$20K |
| 64566 |
|
90 |
54 |
$20K |
| 0124A |
|
602 |
587 |
$20K |
| J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj |
14 |
13 |
$19K |
| 95886 |
|
451 |
423 |
$19K |
| 77470 |
|
13 |
13 |
$19K |
| 86832 |
|
850 |
808 |
$18K |
| 82947 |
|
49,607 |
39,071 |
$17K |
| 96415 |
|
55 |
52 |
$17K |
| 85652 |
|
4,825 |
4,594 |
$16K |
| 80051 |
|
37,065 |
32,860 |
$16K |
| 82784 |
|
1,426 |
1,179 |
$16K |
| 84403 |
|
1,211 |
1,036 |
$16K |
| 20611 |
|
68 |
65 |
$15K |
| 84153 |
|
1,020 |
987 |
$15K |
| 92586 |
|
1,850 |
1,659 |
$15K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
220 |
205 |
$15K |
| 94760 |
|
4,692 |
4,338 |
$14K |
| 83540 |
|
869 |
814 |
$14K |
| 97162 |
|
1,599 |
1,488 |
$14K |
| 97113 |
|
469 |
266 |
$14K |
| 0054A |
|
414 |
406 |
$14K |
| 76830 |
Ultrasound, transvaginal |
95 |
84 |
$14K |
| 83020 |
|
815 |
551 |
$13K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
847 |
548 |
$13K |
| 73564 |
|
148 |
118 |
$12K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
80 |
77 |
$12K |
| 95811 |
|
19 |
16 |
$12K |
| 82950 |
|
2,781 |
2,666 |
$12K |
| J7325 |
Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg |
39 |
36 |
$11K |
| 0352U |
|
544 |
524 |
$10K |
| 77334 |
|
64 |
42 |
$10K |
| 84520 |
|
37,083 |
32,861 |
$10K |
| 86160 |
|
490 |
466 |
$10K |
| 77336 |
|
119 |
51 |
$10K |
| 84466 |
|
858 |
802 |
$10K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
182 |
152 |
$10K |
| 77301 |
|
15 |
12 |
$9K |
| 92250 |
|
312 |
296 |
$8K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
25 |
24 |
$8K |
| 73110 |
|
191 |
149 |
$8K |
| 87497 |
|
62 |
39 |
$8K |
| 82570 |
|
1,271 |
1,185 |
$8K |
| 71045 |
Radiologic examination, chest; single view |
4,278 |
3,924 |
$7K |
| 73130 |
|
190 |
148 |
$7K |
| 82075 |
|
5,173 |
568 |
$7K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
60 |
56 |
$7K |
| 86833 |
|
849 |
805 |
$7K |
| 82728 |
|
639 |
587 |
$7K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
752 |
717 |
$7K |
| 83970 |
|
315 |
296 |
$6K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
679 |
656 |
$6K |
| 80320 |
|
68 |
54 |
$6K |
| 11102 |
|
15 |
12 |
$6K |
| 84439 |
|
879 |
854 |
$6K |
| 83883 |
|
291 |
233 |
$6K |
| 73502 |
|
107 |
101 |
$6K |
| 90480 |
|
332 |
315 |
$6K |
| 93976 |
|
57 |
53 |
$6K |
| 0013A |
|
63 |
63 |
$6K |
| 86704 |
|
133 |
120 |
$6K |
| 80305 |
|
2,075 |
675 |
$5K |
| 87077 |
|
238 |
222 |
$5K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
28 |
25 |
$5K |
| 76942 |
|
288 |
256 |
$5K |
| 97161 |
|
734 |
695 |
$5K |
| 84156 |
|
1,235 |
1,146 |
$5K |
| 90656 |
|
262 |
255 |
$5K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
10,492 |
9,354 |
$5K |
| 91320 |
|
281 |
266 |
$5K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
54 |
51 |
$4K |
| 82043 |
|
346 |
339 |
$4K |
| 83615 |
|
3,435 |
2,065 |
$4K |
| 97164 |
|
295 |
273 |
$4K |
| 95913 |
|
17 |
16 |
$4K |
| C1893 |
Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away |
283 |
247 |
$4K |
| 85730 |
|
270 |
250 |
$4K |
| 92020 |
|
62 |
52 |
$4K |
| 50200 |
|
21 |
14 |
$4K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
40 |
39 |
$4K |
| 86317 |
|
152 |
135 |
$3K |
| 80069 |
|
403 |
388 |
$3K |
| J7323 |
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose |
26 |
12 |
$3K |
| 86480 |
|
125 |
110 |
$3K |
| 86635 |
|
13 |
12 |
$3K |
| 86665 |
|
91 |
77 |
$3K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
78 |
73 |
$3K |
| 83013 |
|
102 |
100 |
$3K |
| J2400 |
Injection, chloroprocaine hydrochloride, per 30 ml |
350 |
288 |
$3K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
359 |
316 |
$3K |
| 97163 |
|
193 |
183 |
$3K |
| 86300 |
|
167 |
144 |
$3K |
| 87522 |
Neg quan hep c or qual rna |
44 |
39 |
$2K |
| 86355 |
|
128 |
120 |
$2K |
| 85046 |
|
1,378 |
1,236 |
$2K |
| 84550 |
|
4,373 |
2,430 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
3,680 |
3,238 |
$2K |
| 86364 |
|
256 |
248 |
$2K |
| 76642 |
|
18 |
14 |
$2K |
| 81002 |
|
61 |
60 |
$2K |
| 77073 |
|
96 |
93 |
$2K |
| 84165 |
|
982 |
810 |
$2K |
| 82951 |
|
78 |
74 |
$2K |
| 86644 |
|
105 |
91 |
$2K |
| 69210 |
|
32 |
30 |
$2K |
| 0071A |
|
25 |
23 |
$2K |
| 20550 |
|
14 |
13 |
$2K |
| 86787 |
|
105 |
88 |
$2K |
| 88112 |
|
161 |
151 |
$2K |
| 93325 |
|
25 |
24 |
$2K |
| 58300 |
|
12 |
12 |
$2K |
| 0072A |
|
21 |
21 |
$2K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
17 |
17 |
$2K |
| 73560 |
|
44 |
39 |
$2K |
| 82378 |
|
318 |
257 |
$2K |
| 86828 |
|
171 |
166 |
$2K |
| 86225 |
|
151 |
142 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,679 |
1,912 |
$2K |
| 86765 |
|
13 |
12 |
$2K |
| 86708 |
|
40 |
39 |
$2K |
| 95874 |
|
138 |
126 |
$2K |
| 83521 |
|
662 |
543 |
$2K |
| 86255 |
|
82 |
79 |
$2K |
| 97597 |
|
23 |
13 |
$1K |
| 16020 |
|
20 |
14 |
$1K |
| 86141 |
|
140 |
134 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,288 |
1,089 |
$1K |
| 86356 |
|
128 |
120 |
$1K |
| 84702 |
|
96 |
65 |
$1K |
| 77077 |
|
28 |
28 |
$1K |
| 90734 |
|
29 |
25 |
$1K |
| 84450 |
|
337 |
325 |
$1K |
| A4649 |
Surgical supply; miscellaneous |
157 |
135 |
$1K |
| 84480 |
|
103 |
102 |
$1K |
| 73590 |
|
16 |
12 |
$1K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,260 |
1,122 |
$1K |
| 82607 |
|
136 |
132 |
$1K |
| 86696 |
|
13 |
12 |
$1K |
| 82670 |
|
96 |
55 |
$1K |
| 86695 |
|
13 |
12 |
$1K |
| 97760 |
|
25 |
25 |
$1K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
25 |
25 |
$959.19 |
| 76937 |
|
14 |
12 |
$935.63 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
45 |
42 |
$928.09 |
| 83605 |
|
25 |
24 |
$925.14 |
| 36416 |
|
2,073 |
1,618 |
$897.18 |
| 97116 |
|
136 |
86 |
$877.89 |
| 82952 |
|
65 |
61 |
$867.11 |
| 0450 |
Emergency room services |
17 |
13 |
$862.04 |
| 90678 |
|
24 |
13 |
$819.54 |
| 64644 |
|
15 |
12 |
$803.36 |
| 77300 |
|
22 |
12 |
$795.24 |
| 90662 |
|
95 |
90 |
$784.57 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,853 |
1,514 |
$778.52 |
| 82077 |
|
375 |
323 |
$763.05 |
| 76857 |
|
78 |
70 |
$735.84 |
| 90674 |
|
18 |
15 |
$699.26 |
| 83861 |
|
25 |
25 |
$691.68 |
| 82977 |
|
25 |
24 |
$687.39 |
| 86235 |
|
96 |
94 |
$672.43 |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
32 |
12 |
$623.84 |
| 97012 |
|
112 |
71 |
$612.26 |
| 36591 |
|
131 |
75 |
$602.03 |
| 84460 |
|
338 |
326 |
$561.90 |
| 83690 |
|
3,386 |
3,184 |
$532.27 |
| 90832 |
Psychotherapy, 30 minutes with patient |
20 |
15 |
$494.03 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
11,108 |
8,065 |
$478.49 |
| 86706 |
|
25 |
24 |
$441.74 |
| 97014 |
|
381 |
262 |
$434.52 |
| 92523 |
|
14 |
14 |
$431.29 |
| 84703 |
|
52 |
50 |
$396.37 |
| 92567 |
|
39 |
30 |
$382.88 |
| 86003 |
|
41 |
40 |
$380.73 |
| 96119 |
|
109 |
88 |
$379.35 |
| C1769 |
Guide wire |
362 |
332 |
$361.87 |
| 90677 |
|
14 |
13 |
$349.20 |
| 93296 |
|
13 |
13 |
$334.15 |
| 83014 |
|
102 |
100 |
$331.35 |
| 85007 |
|
29 |
27 |
$325.13 |
| 87631 |
|
16 |
16 |
$311.49 |
| 84080 |
|
28 |
25 |
$301.75 |
| 86849 |
|
29 |
28 |
$248.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
364 |
276 |
$239.72 |
| J1790 |
Injection, droperidol, up to 5 mg |
102 |
98 |
$239.72 |
| 86200 |
|
73 |
70 |
$200.85 |
| 82248 |
|
14 |
12 |
$198.18 |
| 82746 |
|
48 |
44 |
$187.34 |
| 64450 |
|
13 |
13 |
$183.66 |
| 93280 |
|
13 |
12 |
$171.52 |
| J7999 |
Compounded drug, not otherwise classified |
67 |
64 |
$169.26 |
| 86038 |
|
55 |
54 |
$150.29 |
| 86431 |
|
70 |
67 |
$140.62 |
| 96401 |
|
21 |
14 |
$122.31 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,161 |
1,005 |
$120.23 |
| 86807 |
|
12 |
12 |
$114.64 |
| 97035 |
|
44 |
27 |
$85.25 |
| 86334 |
|
30 |
24 |
$74.57 |
| 11045 |
|
13 |
12 |
$68.93 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
12 |
12 |
$68.78 |
| 82550 |
|
16 |
15 |
$56.50 |
| J7050 |
Infusion, normal saline solution, 250 cc |
50 |
43 |
$55.19 |
| 88313 |
|
13 |
13 |
$54.62 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
701 |
664 |
$49.80 |
| 86645 |
|
62 |
53 |
$46.83 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,404 |
2,108 |
$45.97 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
2,176 |
2,109 |
$41.06 |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
43 |
38 |
$34.62 |
| 90837 |
Psychotherapy, 53 minutes with patient |
22 |
13 |
$25.09 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,327 |
1,174 |
$19.37 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
232 |
153 |
$18.65 |
| 0011A |
|
44 |
41 |
$16.94 |
| J2704 |
Injection, propofol, 10 mg |
10,272 |
4,880 |
$9.76 |
| 84157 |
|
13 |
12 |
$4.65 |
| J0688 |
Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg |
44 |
38 |
$3.60 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
849 |
726 |
$3.43 |
| 82945 |
|
13 |
12 |
$2.33 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
155 |
122 |
$0.00 |
| A9578 |
Injection, gadobenate dimeglumine (multihance multipack), per ml |
12 |
12 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
641 |
592 |
$0.00 |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
57 |
51 |
$0.00 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
484 |
453 |
$0.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
13 |
13 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
41 |
39 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
693 |
637 |
$0.00 |
| G8985 |
Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
181 |
169 |
$0.00 |
| 92557 |
|
109 |
92 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
27 |
26 |
$0.00 |
| G8984 |
Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals |
165 |
154 |
$0.00 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
13 |
12 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
34 |
29 |
$0.00 |
| 99152 |
|
42 |
39 |
$0.00 |
| 97811 |
|
22 |
13 |
$0.00 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
41 |
40 |
$0.00 |
| 97810 |
|
22 |
13 |
$0.00 |
| 98940 |
|
18 |
12 |
$0.00 |
| J2401 |
Injection, chloroprocaine hydrochloride, per 1 mg |
14 |
13 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
20 |
12 |
$0.00 |
| G8990 |
Other physical or occupational therapy primary functional limitation, current status, at therapy episode outset and at reporting intervals |
15 |
14 |
$0.00 |
| E0190 |
Positioning cushion/pillow/wedge, any shape or size, includes all components and accessories |
15 |
12 |
$0.00 |
| V2632 |
Posterior chamber intraocular lens |
120 |
103 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
363 |
301 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
198 |
181 |
$0.00 |
| 88342 |
|
12 |
12 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
68 |
39 |
$0.00 |
| 99385 |
|
13 |
12 |
$0.00 |
| G8982 |
Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
46 |
41 |
$0.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
119 |
118 |
$0.00 |
| 93320 |
|
25 |
24 |
$0.00 |
| A4217 |
Sterile water/saline, 500 ml |
20 |
14 |
$0.00 |
| 94761 |
|
108 |
95 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
31 |
27 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
20 |
20 |
$0.00 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
54 |
29 |
$0.00 |
| G8981 |
Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals |
29 |
27 |
$0.00 |
| 96376 |
|
15 |
13 |
$0.00 |
| G8991 |
Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
15 |
14 |
$0.00 |
| 0012A |
|
16 |
15 |
$0.00 |